Provided by Tiger Fintech (Singapore) Pte. Ltd.

Qudian Inc.

2.79
-0.0150-0.54%
Volume:155.85K
Turnover:435.12K
Market Cap:527.49M
PE:103.86
High:2.83
Open:2.81
Low:2.76
Close:2.80
Loading ...

Blueprint Medicines Highlights Leading Portfolio of Mast Cell-Targeted Therapies at 2025 AAAAI / WAO Joint Congress

PR Newswire
·
28 Feb

Revolution Medicines Reports Fourth Quarter and Full Year 2024 Financial Results and Update on Corporate Progress

GlobeNewswire
·
27 Feb

February 2025's Top US Penny Stocks To Watch

Simply Wall St.
·
19 Feb

Arcus Biosciences Retains Rights to Casdatifan, a Potential Best-in-Class HIF-2a Inhibitor, and Announces Pricing of $150 Million Common Stock Offering

Business Wire
·
18 Feb

New Data Demonstrated Best-in-Class Potential for Casdatifan, a HIF-2a Inhibitor, in Patients with Metastatic Kidney Cancer

Business Wire
·
16 Feb

QD Laser, Inc. Reports Mixed Financial Results Amid Sales Growth

TIPRANKS
·
13 Feb

QD Laser 9-Mos Parent Loss Y328.00M Vs Loss Y369.00M

Dow Jones
·
13 Feb

Third Harmonic Bio Announces Phase 1 Clinical Results for THB335 and Provides Corporate Strategic Update

GlobeNewswire
·
11 Feb

Arcus Biosciences to Present New Data from Casdatifan, a HIF-2a Inhibitor, in an Oral Presentation at the 2025 ASCO GU Symposium

Business Wire
·
11 Feb

Pfizer Reports Strong Full-Year 2024 Results And Reaffirms 2025 Guidance

Business Wire
·
04 Feb

Stock Track | Qudian Inc. Plummets 5.05% as Auditor Change Raises Concerns Over Financial Reporting

Stock Track
·
01 Feb

Qudian Inc. Announces Appointment of Auditor

THOMSON REUTERS
·
31 Jan

Qudian Inc. Announces Appointment of Auditor

PR Newswire
·
31 Jan

3 Promising Penny Stocks On US Exchanges In January 2025

Simply Wall St.
·
21 Jan

C4 Therapeutics Announces 2025 Milestones Across Clinical Portfolio of Degrader Medicines Pursuing Targets of High Unmet Need in Oncology

GlobeNewswire
·
14 Jan

Nurix Therapeutics Outlines 2025 Goals and Objectives for Advancement of Its Robust Pipeline in Cancer and Autoimmune Diseases

GlobeNewswire
·
13 Jan